Skip to content

Drug interactions

Enzalutamide + Sofosbuvir-velpatasvir-voxilaprevir

Severity: Major

Enzalutamide and Sofosbuvir-velpatasvir-voxilaprevir: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Enzalutamide, a strong CYP3A4 inducer that also induces P-gp, may markedly reduce velpatasvir, voxilaprevir and sofosbuvir exposure. This could cause HCV treatment failure.

What this interaction means in plain words

Enzalutamide and Sofosbuvir-velpatasvir-voxilaprevir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Enzalutamide belongs to Endocrine; Sofosbuvir-velpatasvir-voxilaprevir belongs to Anti Virals.

Evidence level: Moderate

Why it happens

Enzalutamide induces CYP3A4 and P-gp, accelerating clearance of the antiviral components.

What to do

Avoid the combination and defer HCV therapy until enzalutamide can be stopped, or seek specialist advice on alternatives. If unavoidable, monitor HCV RNA closely.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Enzalutamide and Sofosbuvir-velpatasvir-voxilaprevir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Enzalutamide with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates the interaction as major. Enzalutamide and Sofosbuvir-velpatasvir-voxilaprevir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Enzalutamide, a strong CYP3A4 inducer that also induces P-gp, may markedly reduce velpatasvir, voxilaprevir and sofosbuvir exposure. This could cause HCV treatment failure.

How serious is the interaction between Enzalutamide and Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination and defer HCV therapy until enzalutamide can be stopped, or seek specialist advice on alternatives. If unavoidable, monitor HCV RNA closely.

What other medicines interact with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir-voxilaprevir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Sofosbuvir-velpatasvir-voxilaprevir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in